Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14)
SGX:T14
Total Valuation
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has a market cap or net worth of $3.85B. The enterprise value is ―.
Market Cap$3.85B
Enterprise Value―
Share Statistics
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has 200,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding200,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee1.67M
Profits Per Employee197.17K
Employee Count4,913
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S is 8.0. Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s PEG ratio is ―.
PE Ratio8.0
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had revenue of 8.22B and earned 986.71M in profits. Earnings per share was 1.28.
Revenue8.22B
Gross Profit3.62B
Operating Income1.10B
Pretax Income1.10B
Net Income986.71M
EBITDA1.26B
Earnings Per Share (EPS)1.28
Cash Flow
In the last 12 months, operating cash flow was 884.91M and capital expenditures 0.00, giving a free cash flow of 804.52M billion.
Operating Cash Flow884.91M
Free Cash Flow804.52M
Free Cash Flow per Share4.02
Dividends & Yields
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S pays an annual dividend of $0.35, resulting in a dividend yield of 5.12%
Dividend Per Share$0.35
Dividend Yield5.12%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.22
52-Week Price Change52.17%
50-Day Moving Average3.23
200-Day Moving Average2.97
Relative Strength Index (RSI)46.43
Average Volume (3m)117.62K
Important Dates
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S upcoming earnings date is Aug 19, 2026, Before Open (Not Confirmed).
Last Earnings DateApr 29, 2026
Next Earnings DateAug 19, 2026
Ex-Dividend Date―
Financial Position
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has paid 126.66M in taxes.
Income Tax126.66M
Effective Tax Rate―
Enterprise Valuation
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has $1.45B in cash and marketable securities with ― in debt, giving a net cash position of $214.05M billion.
Cash & Marketable Securities$1.45B
Total Debt―
Net Cash$214.05M
Net Cash Per Share$1.07
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-23.87%
EPS Growth Forecast-1.03%